[Systemic secondary AA amyloidosis].
Cadiñanos J, Costa R, Trujillo D, Real de Asúa D.
Med Clin (Barc). 2015 Apr 8;144(7):324-30. doi: 10.1016/j.medcli.2014.05.024. Epub 2014 Jul 11.
Secondary, AA, Amyloidosis.
Papa R, Lachmann HJ.
Rheum Dis Clin North Am. 2018 Nov;44(4):585-603. doi: 10.1016/j.rdc.2018.06.004. Epub 2018 Sep 7.
Successful use of tocilizumab in amyloidosis secondary to systemic juvenile idiopathic arthritis.
Gupta A, Bagri NK, Tripathy SK, Barwad A, Phulware RH, Hari P.
Rheumatol Int. 2020 Jan;40(1):153-159. doi: 10.1007/s00296-019-04363-z. Epub 2019 Jul 4.
Systemic Amyloid A Amyloidosis Secondary to Xanthogranulomatous Pyelonephritis.
Habuka M, Nishikiori M, Oikawa C, Takahashi M, Sakamaki Y, Ogawa A, Miyajima N, Tanabe Y, Honma K, Wakaki K, Yamamoto S, Narita I.
Intern Med. 2024 Feb 15;63(4):593-599. doi: 10.2169/internalmedicine.1806-23. Epub 2023 Jul 5.
[Systemic amyloidosis secondary to xanthogranulomatous pyelonephritis].
Almirall J, López T, Sáez A, Gratacós J, Prats J.
Nefrologia. 2001 Sep-Oct;21(5):505-8.
Renal transplantation in secondary systemic amyloidosis.
Heering P, Hetzel R, Grabensee B, Opelz G.
Clin Transplant. 1998 Jun;12(3):159-64.
Amyloidosis.
Comenzo RL.
Curr Treat Options Oncol. 2006 May;7(3):225-36. doi: 10.1007/s11864-006-0015-8.
Uncovering the knowledge about systemic amyloidosis relevant to the rheumatologists.
Pereira IA, Neto NSR, do Nascimento RRNR, Freire EAM, Neves FS, Bica BERG, Pinheiro FAG, Perazzio SF, Cordeiro RA, Giardini HAM, Azevedo VF, Sztajnbok FR.
Adv Rheumatol. 2024 Sep 16;64(1):71. doi: 10.1186/s42358-024-00399-3.
OCULAR MANIFESTATIONS OF SYSTEMIC AMYLOIDOSIS.
Reynolds MM, Veverka KK, Gertz MA, Dispenzieri A, Zeldenrust SR, Leung N, Pulido JS.
Retina. 2018 Jul;38(7):1371-1376. doi: 10.1097/IAE.0000000000001901.
Macroglossia secondary to systemic amyloidosis: case report and literature review.
Xavier SD, Bussoloti IF, Müller H.
Ear Nose Throat J. 2005 Jun;84(6):358-61.
